LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
26.72
-1.18 (-4.23%)
At close: Dec 5, 2025, 4:00 PM EST
26.71
-0.01 (-0.04%)
After-hours: Dec 5, 2025, 7:56 PM EST
LENZ Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for LENZ Therapeutics stock have an average target of 56.25, with a low estimate of 50 and a high estimate of 67. The average target predicts an increase of 110.52% from the current stock price of 26.72.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 20, 2025.
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Reiterates $40 → $50 | Buy | Reiterates | $40 → $50 | +87.13% | Oct 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $51 → $67 | Buy | Maintains | $51 → $67 | +150.75% | Oct 10, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $49 → $52 | Strong Buy | Maintains | $49 → $52 | +94.61% | Aug 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $56 | Strong Buy | Maintains | $48 → $56 | +109.58% | Aug 1, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $49 | Strong Buy | Maintains | $45 → $49 | +83.38% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
17.40M
Revenue Next Year
53.02M
from 17.40M
Increased by 204.72%
EPS This Year
-2.69
from -2.34
EPS Next Year
-2.86
from -2.69
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 22.7M | 63.6M | ||||
| Avg | 17.4M | 53.0M | ||||
| Low | 5.9M | 40.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 265.7% | ||||
| Avg | - | 204.7% | ||||
| Low | - | 131.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.57 | -2.09 | ||||
| Avg | -2.69 | -2.86 | ||||
| Low | -2.68 | -3.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.